Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.4.2 to the page and removed older entries including the funding status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check69 days agoChange DetectedAdded a site-wide notice about government funding and current NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedAdded Show glossary and updated QC metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removed older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange DetectedThe changes are minor revision notes: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.